Upload
flomax23
View
215
Download
0
Embed Size (px)
Citation preview
8/12/2019 ID drugs
1/12
Key Words : Ototoxicity, Nephrotoxicity or Renal toxicity, Hepatotoxicity, Hematopoietic toxicity, Bactericidal, CYP3A4 Inducer/inhibitor, Cross-react
Antibacterial ChemotherapyClass Drug Name Mechanism/pharmacokinetics/Resistance Indications Adverse effects
Inhibitor of Cell Wall Synthesis (ICWS)
B - L a
c t a m s P e n i c i l
l i n s
M e c h a n i s m
o f A c t i o n s :
1 -
C o v a
l e n
t b i n d i n g t o
t r a n s p e p
t i d a s e s
/ P B P s
2 -
I n h i b i t t r a n s p e p
t i d a
t i o n
r x n
( c r o s s - l
i n k i n g o
f c e
l l w a
l l )
3 -
A c
t i v a
t i o n o
f M u r e
i n h y
d r o
l a s e s
( a u
t o l y s
i n s
)
A l l a r e
b a c
t e r
i c i d a
l ! ! ! !
Pen G
Pen V
Pen G oral/parenteral, Pen V oral; Benzathine depot ; acid labile
Pen G: particularly for Group B Strep (GBS)
Gram(+) cocci In general to all penicillin:-Hypersensitivity reaction
is the major penicillinadverse effect. About 5-8% claim allergic to pens.
Seizure by high dose penicillins (particularly
renal failure )
Nafcillin ,Methicillin ,
Isoxazolyl penicillins(ox-, clox-)Oxacillin
Cloxacillin
Oral; nafcillin and oxacillin parenteral too; ox- clox- and diclox acid-stable
All B-Lactams: Bactericidal Time dependent .PharmK: poor distribution to eye, prostate, and CNS.
Anti-Staphyloccocal penicillins
B-lactamaseresistant!! , Staph.
aureus
Carbenicillin indanyl ,Piperacillin ,Ticarcillin ,
Mezlocillin
Effective against Proteus , Pseudomonas . Problem: rapid emergencew/Pseudomonas, so use in combo w/ aminoglycosides or
fluoroquinolones . Note: these are powerful Rx, use only whenindicated to protect their therapeutic value
Anti-PseudomonalPenicillins
Ampicillin,Amoxicillin ,
Increased gram(-) activity Extended SpectrumPenicillins
Gram +/-
Ampicillin Rash (10%incidence, 90% in ptx w/
mononucleosis)
-Same general contra asabove
B-Lactamaseinhibitor
Clavulanic acid ,
Sulbactam ,Tazobactam
Resistance to Penicillins by B-lactamase production (major
mechanism). Use B-lactamase-resistant penicillin (Nafcillin, oxacillin,cloxacillin) + Co-administer w/ B-lactamase inhibitors!
B-lactamase
resistant
Cephalosporins-In general
Cephalosporins areMore toxic than
penicillins particularly Renal
Toxicity Some
cross-reactivity w/pen-sensitive pts.
1st generationCephalothin Cephalexin (o)Cefazolin
Less sensitive to B-lactamase . Broader spectrum of activity.Clinical use: chemoprophylaxis for surgery , alternative to anti-staph
penicillin.
(ph)
Greater gram-activity
Gram +
5-10% cross-reactivitywith penicillins.
Hypersensitivity, some GI,Renal Toxicity ; plateletinhibition and Disulfram
effect.2nd gen
Cef uroxime(o)CefotetanCef aclor (o)
Intermediate Spectrum
F?
More gram- than 1 st.Less Gram (+)
activity
Cefotetan &cefoperazone: Disulfram
effect
3 rd gen
Broad spectrum. Better for CNS Reserve for Gram-
8/12/2019 ID drugs
2/12
Cefotax imeCeftriaxoneCef taz idime
tax, triax, tazactivity
4 th genCefepime
Broad Spectrum. Better distribution (CNS).Cephalosporinase-resistant .
Reserve for gram- activity
Mono-bactams(still b-lactams)NEWER DRUGS!
Aztreonam Gram (-) activity; virtually inactive against Gram (+) or anaerobes.
Resistant to B-lactamase . No cross-reactivity in pen-sensitive
patients
Only good againstGram- activity , B-
lactam resist
Carbapenems
Imipenem Broad spectrum . IV only. Pseudomonas develops resistance rapidly, souse w/ aminoglycosides . Inactivated by renal dipeptidase , co-administer Cilastatin (inhibits enzyme from blocking Imipenem)
Gram (-/+),anaerobes May Cross-reactivity w/penicillins.
Meropenem Dipeptidase-resistant carbapenem. So you give this one as a secondline to Imipenem
May Cross-reactivity w/penicillins.
Other ICWS
Non-B-Lactams
VancomycinBactericidalOtotoxicity
Renal Toxicity
Inhibits transglycosylation (step before transpeptidation). Previouslyclassed as too toxic for systemic use. IV drug cleared through kidney enhances oto- & renal toxicity of aminoglycosides. Red man or red
neck syndrome = histamine release. Misuse/overuse can be aproblem.
Bactericidal forGram (+).
Systemic MRSAVancymycin-d
Nephrotoxic andototoxicity .
Some thrive on thisdrug!!!: Vancomycin-
dependent Enterococci Fosfomycin Newest ICWS. Inhibits cell-wall synthesis from within! At the
cytoplasmic step in cell wall precursor synthesis. Active uptake byglycerophosphate or G6P-transporter. Only oral approved in USA.
Active drug excreted by kidney. Approved for single-dose therapy ofUTI. Synergistic w/ B-lactams , aminoglycosides , or fluoroquinolones .
Gram (-) UTI
Some Gram+ too
BacitracinBactericidal
Topical antibiotic only!!!! Markedly nephrotoxic
Other Polymixin B This agent affects cell membranes. Not sure how. Inhibits G-Polymyxin E Old drug, now used as new drug as last resort. Mech: solubilizes
bacterial membrane.Anti-Pseudomonal
How come the class of anti-staph can be used to treat b-lactamase producing pneumococci?
8/12/2019 ID drugs
3/12
Class Drug Name Mechanism/pharmacokinetics/Resistance Indications Adverse effects
Inhibitor of Protein Synthesis (IPS)Aminoglycosides
Mechanism:irreversible
inactivation ofribosome
(30S).
Irreversible = thinkBactericidal!! !
OtotoxicityRenal Toxicity
Streptomycin
Gentamicin
Tobramycin
Amikacin
BactericidalOtotoxicity
Renal Toxicity
Multiple effects on translation misreading of mRNA, interfere w/ initiation , break up polysomes (streptomycin monosomes) PharmK: poor oral absorption usually given IV, sometimes IM.
Good distribution except for eye and CNS. No significant hostmetabolism. Excretion glomerular filtration. Very high
concentration in proximal tubule cells!!!!.
Administer: One Dose a Day at HIGH CONCENTRATION!!!! Once a day gives us a brief time to kill bacteria and gives us the
rest of the day to relax and avoid the adverse effects: ototoxicity & Nephrotoxicity
Nephrotoxicity: Exacerbated by Vancomycin, cyclosporine
Neuromuscular blockade : seen at very high dose phenomenon.Most common during surgery (d/t other NM blockers), also in
Myasthenia gravis ptx.
Resistance: emerges rapidly if AG used alone.
Non-resistant Gram(-) infections: E. coli,
Proteus,Pseudomonas
For Pseudomonas :
use Gent>Tobra>Amika
Nephrotoxicity!!! : high
concentrations of AG inrenal cortex. 5-25%receiving AG >3 days
shows progressive renalimpairment . Ampho B, or
cisplatinOtotoxicity : high conc ofAG in inner ear. 5-25% of
ptx. Loss of vestibularand/or auditory fxn. May
be reversible.Dose- and Time-
dependent
Neuromuscular
Blockade!!!!!!
Spectinomycin Spectinomycin Related to aminoglycosides. Used againstPenicillin-resistant
gonococci
TetracyclinesHepatotoxicity
Reversible binding to30S subunit.
Bacteriostatic .
Tetracycline
Usually given orally, but absorption variable. Tetracyclines chelatemetal ions : Ca2+, Al3+, Fe2+, Mg2+. Poorly absorbed therefore
DO NOT administer with food, milk, antacids. Rarely given IV.
Well distributed, except to CNS, synovial fluid. Concentrates inteeth, bone, liver (bile), kidney .
Tetracyclines crosses the placenta and are excreted in milk .
Bacterial resistance to Tetracyclines by:-increased efflux pumps are major resistance .
-altered ribosomal proteins or RNA are secondary mechanisms.-Especially common in Pseudomonas, proteus
-indiscriminate use/overuse (clinical & agricultural)
Broad spectrumantibiotics.
Gram (+/-)Mycoplasma ,Chlamydia ,Rickettsiae ,
Lyme disease
Intracellular bugsincluding
spirochetes .
Tick-borne diseases?
GI direct irritation.Superinfections:
Pseudomonas, Proteus,Staph, Clostridia, Candida
Impaired liver function high doses, during
pregnancy, pre-existingliver dz
Photosensitization
Calcium chelation :deposit in teeth & bone leads to discoloration,
growth retardation,deformity.
Doxycycline Excreted mostly fecal; others mostly urine
Glycylcyclines (part Newer generation of tetracyclines. Retain antibacterial spectrum
Tetracycline
8/12/2019 ID drugs
4/12
of Tetracyclines)
Tigecycline
of tetracyclines but overcome resistance .
NOT affected by Efflux pump EXCEPT in Proteus andPseudomonas .
resistant bacteria!!
MacrolideAntibiotics
(older)
Blocks translocation by binding to 50S
subunit
Macrolide Antibiotics (newer)=
50S
Erythromycin ,Clarithromycin,Azithromycin
Clari- and Azi- (broaderspectrum)
Hepatotoxicity
Bacteriostatic or bactericidal , depending on dose
Absorbed from GI tract, but acid-labile. Therefore, we use entericcoating or erythromycin esters to increase stability. Can also beadmin IV. Excellent distribution except to CNS. Crosses placenta.
Excreted in bile ( 50x higher than in plasma ). Half-life 2-5hrs exceptfor azithromycin (a little longer).
Resistance: Staph, some strept- and pneumococci. By altered(methylated) rRNA, efflux pump, esterases
Gram (+),some Gram (-), some
mycobacteria.
Think Atypical
pneumonia !
Mycoplasma or
Legionnaires disease, chlamydia
1. GI distress 2. Microsomal enzymeinhibition (Rx-Rx interx:
oral anti-coagulants,digoxin, non-sedating anti-
histamines)3. Hepatotoxicity esp.erythromycin estolate
cholestatic jaundice!!!! .
Clarithromycin Higher availability ~Less GI effects
Azithromycin Minimal P450-based interactions
Tissue level 10-100x plasma levels!!!T1/2 = 2-4 days.
Higher availability~Active against mycobacterium avium-intracellulare (MAC) in
AIDS patients
Chlamydia
Active against(MAC) in AIDS
patients
High intracellular concentration !!!
Ketolides(macrolide-like)
50S
Telithromycin
Semi-synthetic macrolide. Oral, well absorbed and distributed.Metabolized in liver, excreted in both bile and urine. Poor
substrate for efflux pump . ONCE daily dosing !!
Used for respiratory tract infections (community-acquiredpneumonia, bronchitis, sinusitis). Inhibits CYP3A4
Doesnt have thatefflux problem
macrolides have. QT Prolongation!!
Other Proteinsynthesis inhibitors
50SChloramphenicol
Hematopoietictoxicity
Reversible inhibitor of protein synthesis. Bacteriostatic . Broadspectrum. Well absorbed from all routes, CNS levels = Serum .
100% excreted in urine (10%filtrate, 90% tubular sec).Glucuronidation in liver is rate-limiting step for
inactivation/clearance for drug.
Resistance: key mechanism is plasmid-mediated . Chloramphenicol
Acyl Transferase (CAT). Slow development. Only slight resistance(2-4x). Ideal drug; however, too many adverse effects.
Typhoid fever, RockyMountain spotted
fever in children.
1) GI disturbances followed by fungal
superinfections.2) Anemia d/t BM
depression .3) Aplastic Anemia
usually irreversible & oftenfatal.
4) Gray Baby syndrome (poor glucuronidators)
5) Drug-drug interactions inhibits microsomal
enzymes.ClindamycinHepatotoxicity
Lincosamide antibiotic . Bacteriostatic . Well-absorbed anddistributed, except for CNS.
Bacteroides fragilis,other anaerobes.
GI upset,Clostridium
8/12/2019 ID drugs
5/12
Endocarditisprophylaxis
superinfection ,
Hepatotoxicity Other
Streptogramins :50S
Newer drugs!
QuinupristinDalfopristin(Synercid TM)Bactericidal
Peptide macrolactones. IV, 80% excreted in bile, 20% in urine.POTENT Protein inhibitor of CYP3A4.
Bacteriostatic against Enterococcus faecium. Bactericidal againstother organisms.
Approved for use against Vanco- and multi-drug resistantEnterococcus faecium, Methicillin-resistant Staph. Aureus (MRSA).
VRE, MRSA SERIOUS INDICATIONSHERE FOR DRUG-DRUG
INTERACTIONS
OtherOxazolidinones
Prevents formation of70S ribosomes
(unique!)
Linezolid(can inhibit MAOI)
Bactericidal
No cross-resistance w/ other IPS. Bactericidal againststreptococci .
Bacteriostatic against staph and enterococci.IV or oral, Oral AUC = IV AUCGood distribution to tissues.
Primary: Vanc -resistant E. faecium (Limit to multi-drug
resistant Gram+infections)
BM suppression ,Thrombocytopenia (reversible & mild)
Class Drug Name Mechanism/pharmacokinetics/Resistance Indications Adverse effects
Inhibitor of Folate Dependent Pathwaysp-Aminobenzoic Acid
analogs ( PABA)
Inhibitors of FolateSynthesis
SulfonamidesHematopoietic toxicity
Renal Toxicity
Silver Sulfadiazine PABA analog . Enter into a normal metabolic pathway, butthen blocks that pathway. Competitive inhibitor of
dihydrofolate synthesis . Biostatic
Oral, some topical (burns), rarely IV. Well absorbed in GI, welldistributed including CNS. Variable metabolism, depending on
drug and patient. Acetylation yields inactive metabolite .Excreted in urine (90% by glomerular filtration). 10-20x blood
concentration in urine.
Topical application forburns
Allergic reaction: fever,rash (up to 5% incidence)-May cross react w/ othersulfonamides carbonic
anhydrase inhibitors,thiazides, furosemide,
sulfonylureahypoglycemic.
SodiumSulfacetamide
Ophthalmic preparations
Sulfasalazine(not absorbed-split bygut bacteria to release
aminosalicylate)
Ulcerative colitis
8/12/2019 ID drugs
6/12
Inhibits Pteridinesynthetase UTI uncomplicated, untreated, acute.
Sulfonamides are now combined with trimethoprim.
Resistance: mutations overproduction of PABA. Loss ofpermeability. New form of dihydropteroate synthetase
enzyme can discriminate b/t PABA vs sulfonamide.
Stevens-Johnsonsyndrome (fever, malaise,
rare but can be fatal).-Crystalluria/ hematuria -Hematopoietic effects
-Hemolytic anemias (G6PDH deficiency)
Inhibitor of Folate use:
Dihydrofolatereductase (DHFR)
inhibitors
Trimethoprim
Blocks bacterial enzyme. Blocks dihydrofolate reductase . Readily absorbed from GI. Wide distribution including CNS.
Excreted in urine. Can be used alone for UTI, but usuallycombined w/ sulfonamide (TMP-SMX). Combination is often
bactericidal.10,000x more effective against bacterial DHFR than againstmammalian enzyme, but still may see anti -folate effects.
Pneumocystispneumonia, complicated
UTI.
Megaloblastic anemia ,
leukopenia ,
granulocytopenia . Treat
w/ folinic acid . (easyfix!)
CombinationBactrim
orTrimethoprim-
Sulfamethoxazole (Co-trimoxazole) aka
TMP-SMX
Combo = bactericidal.
Typical sulfonamideeffects.
AIDS ptx receiving Co-
trimoxazole = higherincidence of adverseeffects . Fever, rashes ,leukopenia , diarrhea
Class Drug Name Mechanism/pharmacokinetics/Resistance Indications Adverse effects
DNA Gyrase InhibitorQuinolones
bactericidal
Nalidixic Acid Prototype quinolone antibiotic.
Inhibits transcription and DNA replication .Oral admin, rapidly absorbed, rapidly metabolized (glucuronidation),
and excreted in urine
Anti-malarial drugs??
Fluoroquinolones
Bactericidal!
Ciprofloxacin Levofloxacin
Ofloxacin
Fluorinated analogues of nalidixic acid. Well absorbed & distributedafter oral administration. Only 20% is metabolized (liver). Excreted
in urine, blocked by probenicid . Effective systemically after oraldose, parenteral forms also available.
Resistance: altered (mutated) DNA gyrase, especially Pseudomonas ,Staph, Serratia
Broad-spectrum
Excellent against Gram-. Useful in GI & UTIs.Shows promise for
treatment of respiratory,skin, soft tissue
infections, esp. multi-drug resistant organisms.
Moderate-good:Gram(+)
Some GI: nausea,vomiting, diarrhea.
HA, dizziness, insomnia,abnormal liver fxn tests .
Blocks theophyllineclearance (cannot be co-admin, duh!). Connective
tissue dsd?
8/12/2019 ID drugs
7/12
Class Drug Name Mechanism/pharmacokinetics/Resistance Indications Adverse effects
Urinary Tract Antiseptics-Use systemic agents, which are efficiently cleared in the urine: Penicillins, Aminoglycosides, Sulfonamides, Fluoroquinolones.
Resistance and re-infections are common. May need to suppress bacteria for a long time.Nitrofurantoin Mechanism is unknown, but may involve oxidative stress.
Bacteriostatic or cidal depends on bug. Rapidly absorbed (oral),metabolized, and excreted in urine (50% as active drug). Even IV does
not have a systemic effect.
Resistance: all Pseudomonas , some Proteus
UTI, Gram+/- ,most effective ifurine pH
8/12/2019 ID drugs
8/12
Ethambutol Inhibits synthesis of mycobacterial cell wall glycan (arabinogalactan ?). Well absorbed and distributed. CNS level
variable, 4-60% of serum. Most excreted in urine accumulates inrenal failure.
Resistance: rapid, therefore use in combo
Dose-dependent opticneuritis , decreased acuity ,
loss of red -green differentiation .
Streptomycin Was only for severe ( life-threatening ) cases, now used morefrequently. PK.
adverse effects typical ofaminoglycoside
IV every day forprophylaxis.. not an ideal
drug choice!2nd line Anti-TB
drugsPara-
aminosalicylate (PAS)
Currently a resurgence in TB, highly resistant strains are common.2nd line may become 1 st line. Other drugs include: amikacin,
Ciprofloxacin, OfloxacinCycloserine
EthionamideSulfone Dapsone Similar to sulfonamide. Well absorbed and distributed.
Concentrates in skin, muscle, liver, and kidney. Acetylated; excretedin feces and urine.
Dr. Z: inhibits folic acid synthesis.
Used in combination w/rifampin and clofazimine
for M. Leprae . Also may beused for P. jiroveci
pneumonia.
Hemolysis andmethemoglobinemia
common.
8/12/2019 ID drugs
9/12
Anti-Fungal ChemotherapyDrug Mechanism/Phamacokinetics Clinical Use Adverse effect
Class: Systemic Anti-Fungal Agents Amphotericin B ampotherrible drug lotsof side effects
Binds Ergosterol (essential component of fungal membrane)
A: IV or intrathecal (into CSF)D: good (except CNS)t 1/2 = 2 weeks (slow)- (side effects dont stop until drug is
gone).Add to Liposomes drug will have higher affinity to liposomethan to OUR memb lower side effects. Liposome = buffer
Most important drug for severesystemic mycosesBroad spectrumUse initially then switch (toxic)
Concentration is greatest:Fungi > liposome > our cell membrane
Chills, fever, nausea, vomiting,headache
(premedicate: antipyretics,antihistamines, analgesics)
Nephrotoxicity
FlucytosineInhibitor of nucleic acidsynthesis! Anti-cancerdrug.
Only fungi have cytosinedeaminase!
Antimetabolite! Fungal cytosine deaminase converts 5-Fluorocytosine to 5-fluorouracil (5-FU)Block DNA & RNA syn
Use is limited because only some fungi are susceptible andonly given independently = rapid resistance!A: Orally effective,D:widely distributed ( even CNS ),E:urine (10x serum)
Cryptococcus, some CandidaRapid resistance use w/ AmphotericinB or itraconazole
Low toxicity
Anti-Fungal Azoles Azoles all inhibit Ergosterol synthesis (blocks fungal CYP450) Ketoconazole Inhibit Ergosterol synthesis
A: 1 st oral antifungal for systemic diseaseD: Not into CNS
Not widely used anymore
Used as adjunct therapy for prostatecancer (androgen dependent)Systemic fungal diseaseNot used often b/c of side effects.
GI, hepatotoxicityBlock OUR adrenal steroidogensis
(Gynecomastia )Alters drug metabolism ofcyclosporine, non-sedating
antihistaminesItraconazole Inhibit Erogosterol synthesis
A: Oral and IVHistoplasms, blastomyces, sporothrix Fewer adverse effects than
ketoconazoleFluconazole Inhibit Erogosterol synthesis
Water soluble good CSF deliveryMore selective for fungal P450s
Most widely used. Cryptococcalmeningitis, candidemia,mucocutaneous candidiasis
Voriconazole Inhibit Erogosterol synthesis . Newest triazoleA: Oral and IV M: liverCleanest/purist drug.
Aspergillosis, Candida, Dimorphicfungi
Fewer adverse effects thanketoconazole
Visual disturbances in 30% ofpatients
Inhibitors of cell wall synthesisCaspofungin Inhibits synthesis of cell wall b(1-3) glucan
-Incomplete wall causes lysisLarge cyclic peptide linked to fatty acidIV, highly protein bound, slow metabolism.
Candida , Emperic anti-fungal(neutrophenia)Salvage therapy for amphotericin-resistant Aspergillus
Minor GI
8/12/2019 ID drugs
10/12
E: Urine, feces
Anti-fungal agents for mucocutaneous infections Drug Mechanism/Phamacokinetics Clinical Use Adverse effectTopical Nystatin Similar to Amphotericin B Topical antifungal agent
Can be given orally for intestinal tractToo toxic for systemic use. You
cannot achieve systemicconcentration safe enough for
this drug WORST thanamphotericin B!
Systemic Griseofulvin A: Orally concentrates in keratinized tissue ringworm & athletes foot Terbinafine Similar to Griseofulvin, concentrates in keratinized tissue BUT it does not ACTIVATE until it REACHES TOPICALLOCATION!-Inhibits Squalene epoxidase (ergosterol synthesis)
More commonly used than
Anti-Parasitic Chemotherapy
Drug Mechanism/Phamacokinetics Clinical Use Adverse effectAnti-Malarials
(Plasmodium falciparum, P. malariae, P. vivax, P. ovale) 1st 2 = single cycle; 2 nd 2 = multiple cycles Chloroquine Alters metabolism of hemoglobin by parasite & blocks nucleic acid
synthesisA: Oral or parenteral. Rapid, completeD: wideE: urine, 25% as metaboliteGive loading dose for acute tx (long t1/2)Resistance: in SA, Africa, Asia, common in P.falciparum, in P.
vivax, from P -glycoprotein pumping mechanism
highly effective blood schizonticide Acute: clears parasitemia from all 4
plasmodiaCures: P. falciparum & p. malariae
Use w/ primaquine for P. vivax &ovaleProphylactic of choice : 1 wk before
travel and continue till 4 wk after
Well tolerated Pruritis ; GI, mildheadache; may exacerbatepsoriasis or porphyria
Biggest problem is resistance(efflux pump)
Block efflux w/verapamil (Ca2+channel blocker-so it has side
effects)
Mefloquine UnknownA:oral (to irritating for parenteral) well absorbed,M: liver, excreted in feces
Prophylaxis or tx of chloroquineresistant
GI, CNS, possible psychotropic effects (used in murder defenses!)*Nightmares!
Quinine Inhibits nucleic acid and protein synthesis. Doesnt cross BBB,metabolized by CYP3A4 and CYPs
Back up for Chloroquine-resistant P.falciparum
Cinchonism (HA, nausea, sweating,tinnitus, dizziness, blurred vision)
QT prolongation Atovaquone /
Proguanil (Malarone)Atovaquone : Inhibits ETC, poor oral absorption, high proteinbinding 2-3 half life.
Proguanil : inhibits protozoal dihydrofolate reductase, wellabsorbed, half life 12 hrs, extensive metabolism by CYP2C19, activemetabolite is cycloguanil
Prophylaxis or treatment for P.falciparum resistant.
GI, HA, anorexia, dizziness
8/12/2019 ID drugs
11/12
Fansidar
(pyrimethamine-sulfadozine)
Anti-folate combinationBlocks synthesis/utilization of folic acidWell absorbed, excreted in urine
Use for P. FalciparumSlow acting (Not for acute attacks)
GI distress, cutaneous rxns
Steven-Johnson symptoms
Primaquine This fights protozoans in the LIVER Oral, well absorbed, metabolites are intracellular oxidants
Tissue Schizonticide (goes after liver)Use in combination w/ chloroquinefor prophylaxis or cure of P. vivax orovale
Some GI distress, hemolyticanemia in G6PDH deficiency
Artemisinin Traditional Chinese medicineActivated by oxidative metabolism free radicals, alkylationVery short t 1/2 , oral
Rapidly acting blood schizonticideFor multi-drug resistant P. Falciparum
Artesunate Available through CDC only! Cannot get through pharmacy. Used for severe P. falciparum orwhen oral meds cannot be given!
Other Anti-Protozoal Drugs: Metronidazole
bactericidal Tissue amebicide, Nitroimidazole (activated by electron donation),effective for anaerobic/hypoxic sites Oral or IV, well absorbed and distributed, including CNS, boneCleared in urine (hepatic metabolism)
Intestinal, extraintestinal, urogenitalprotozoal infections (Trichomoniasis,Giardiasis, Amebiasis)Anaerobic Infctions (C. Diff)
Nausea, headache, dry mouth,leucopeniaDisulfram effect (cant drinkalcohol)
Nitozoxanide Inhibits electron transport system pyruvate ferridoxinoxidoreductase (PFOR).
Tx: Giardia lamblia andCryptosporidia parvum. Usefulagainst metronidazole-resistantstrains
Few far better tolerated thanmetronidazole
Pentamidine UnknownIV, IM or aerosol Concentrates in liver, spleen, kidneysDoesnt enter CNS
Aerosol: used for tx & prophylaxis forPneumocystis pneumonia
Respiratory stimulation depression; hypotension, anemiaLess common w/ aerosol
Anti-HelminthicAnti-Helminthic Chemotherapy
Mebendazole Blocks microtubule synthesis , blocks vesicle and organellemovementGiven orally,
8/12/2019 ID drugs
12/12
Rapidly metabolized, excreted in urineAlbendazole Interferes w/ microtubule aggregation, alters glucose uptake
Rapidly and completely metabolized in liver, conjugates excreted inurine
Wide-spec anti-helminthic
Ivermectin Oral treatment for all intestinal Strongyloidiasis andOnchocercasiasInhibits Cl channel and paralyzes worm and they die!
Praziquantel Parent is active species membrane permeability to Ca 2+ resulting in contraction andparalysis80% bioavailability from oral dosingRapidly and extensively metabolized, cleared in urine
Schistosomes, some trematodes andcestodes
Headache, dizziness, drowsiness
Diethylcarbamazine(DEC)
Destroys adult nematodes particularly filarial lymphatic wormsthat causes elephantiasis.
Drug may have severe side effects.
Pyrimethamine-SulfonamideClass Drug Name Mechanism/pharmacokinetics/Resistance Indications Adverse effects